Dipna Pharmachem Ltd. benchmarking: Performance to industry peers

Financial

	Dipna Pharma.	Deccan Health Care	EVOQ Remedies
Operational Metrics
Financials
5 yr Average ROE	16.1 %	0.79 %	21.9 %
5yr average Equity Multiplier	14.87	1.17	3.25
5yr Average Asset Turnover Ratio	1.35	0.47	0.54
5yr Avg Net Profit Margin	0.81 %	1.37 %	6.7 %
Price to Book	0.42	0.28	0.0
P/E	25.18	13.39	90.83
5yr Avg Cash Conversion Cycle	-33.62 Days	218.27 Days	149.18 Days
Inventory Days	62.45 Days	372.92 Days	70.89 Days
Days Receivable	112.8 Days	54.52 Days	160.81 Days
Days Payable	139.84 Days	94.94 Days	163.4 Days
5yr Average Interest Coverage Ratio	2.01	12.96	2683.3
5yr Avg ROCE	12.33 %	2.08 %	29.29 %
5yr Avg Operating Profit Margin	2.41 %	7.39 %	-11.9 %
5 yr average Debt to Equity	5.84	0.02	0.18
5yr CAGR Net Profit	117.34 %	24.36 %	-34.02 %
5yr Average Return on Assets	1.21 %	0.68 %	3.64 %
Shareholdings
Promoter Holding	9.98 %	18.42 %	11.21 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-56.58 %	-3.79 %	-62.32 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Dipna Pharma.	Deccan Health Care	EVOQ Remedies
Segment Break-Up	Segment Break-Up Pharmaceuticals 93.43 Commission 6.57	-	-
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0	Location Wise Break-Up India 99.86 Rest of the World 0.14	Location Wise Break-Up India 100.0 Rest of the World 0